Trademark Overview
On Thursday, March 5, 2026, a trademark application was filed for WAIVE BY LSD with the United States Patent and Trademark Office. The USPTO has given the WAIVE BY LSD trademark a serial number of 99684684. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 5, 2026. This trademark is owned by LSD The Agency Inc.. The WAIVE BY LSD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Software as a service (SaaS) featuring non-downloadable, cloud-based software for facilitating structured stakeholder engagement and advisory programs for strategic planning and brand development within the pharmaceutical and life sciences industry, namely enabling communication, feedback collection, and moderated discussion between pharmaceutical organizations and healthcare professionals, patients, caregivers, and other healthcare stakeholders; providing tools for structured data collection, reporting, and artificial intelligence-assisted analysis and summarization of engagement feedback in support of stakeholder engagement strategy and advisory initiatives in the life sciences sector
